Scientists from Fudan University and Shanghai Traditional Chinese Medical University have developed new substances for medical diagnosis that allowed Parkinson’s disease and similar brain diseases at an early stage. Published in İş Magazine Genomic psychiatry.
Parkinson’s disease is a serious disease associated with impaired brain function. One of the reasons is the accumulation of a special protein-a-sufficient. Previously, it could only be detected after the death of a person who intervened early diagnosis and effective treatment.
Now, scientists have created special substances inserted into the body and followed with pet scanning (positron emission tomography). They help to “highlight the harmful clusters of the protein directly in the living brain.
Huashan Hospital. “This is a real breakthrough. For the first time, we can see changes in disease -related changes during the patient’s life, Fan said.
One of these substances, [18F]The C05-05 has already been successfully tested in patients with signs of Parkinson and dementia. The accumulation of the brain has increased accumulation in regions that suffer from these diseases. In addition, the level of accumulation coincided with the seriousness of symptoms in patients.
Another substance, [18F]The pain-12589 showed itself in the diagnosis of another multi-faceted systemic atrophy. He helped to distinguish him from other similar diseases.
“If we learn to define the disease before the irreversible changes begin, it will change the fate of these millions of people,” he said.
Previously announced The role of sleep in memory mechanisms.
What are you thinking?
Source: Gazeta
Barbara Dickson is a seasoned writer for “Social Bites”. She keeps readers informed on the latest news and trends, providing in-depth coverage and analysis on a variety of topics.